Lafora's Disease. An Ultrastructural and Histochemical Study

Overview

Journal Acta Neuropathol

Specialty Neurology

Date 1974 Jan 1

PMID 4446965

Citations 5

Authors

S Ramon Y Cajal

A Blanes

A Martinez

E Saenz

M Gutierrez

Affiliations

Soon will be listed here.

Citing Articles

Periodic acid-Schiff (PAS)-positive deposits in brain following kainic acid-induced seizures: relationships to fos induction, neuronal necrosis, reactive gliosis, and blood-brain barrier breakdown.

Bennett S, Stevenson B, Staines W, Roberts D Acta Neuropathol. 1995; 89(2):126-38.

PMID: 7732785 DOI: 10.1007/BF00296356.

A type of adult polyglucosan body disease.

Okamoto K, Llena J, Hirano A Acta Neuropathol. 1982; 58(1):73-7.

PMID: 6814164 DOI: 10.1007/BF00692701.

Corpora amylacea in the peripheral nerve axons.

Yagishita S, Itoh Y, Nakano T Acta Neuropathol. 1977; 37(1):73-6.

PMID: 190849 DOI: 10.1007/BF00684544.

Urinary glycosaminoglycans in patients with progressive myoclonus epilepsy.

Federico A, DAuria N J Neurol. 1979; 220(4):291-5.

PMID: 90138 DOI: 10.1007/BF00314153.

[The so-called filaments in lafora-bodies, corpora amylacea and Bielschowsky-bodies. Fasciolar substructures in accumulated intraplasmatic material of cellular dysmetabolies (author's transl)].

NEMETSCHEK T, Volk B, ULE G Acta Neuropathol. 1975; 33(1):79-84.

PMID: 52274 DOI: 10.1007/BF00685967.

References

SEITELBERGER F . [Discussion of the report on progressive myoclonic epilepsy]. Rev Neurol (Paris). 1968; 119(1):139-41. View

Meyer K . Problems of histochemical identification of carbohydrate-rich tissue components. J Histochem Cytochem. 1966; 14(8):605-6. DOI: 10.1177/14.8.605. View

Gambetti P, Di Mauro S, Hirt L, Blume R . Myoclonic epilepsy with lafora bodies. Some ultrastructural, histochemical, and biochemical aspects. Arch Neurol. 1971; 25(6):483-93. DOI: 10.1001/archneur.1971.00490060017002. View

Harriman D, Millar J, Stevenson A . Progressive familial myoclonic epilepsy in three families: its clinical features and pathological basis. Brain. 1955; 78(3):325-49. DOI: 10.1093/brain/78.3.325. View

Roger J, GASTAUT H, BOUDOURESQUES J, TOGA M, Dubois D, LOB H . [Progressive myoclonus epilepsy with Lafora bodies. Clinical and polygraphic study. Anatomical ultrastructural verification]. Rev Neurol (Paris). 1967; 116(3):197-212. View

Schnabel R, SEITELBERGER F . [Histochemical studies on myoclonus bodies in progressive myoclonus epilepsy (Unverricht type)]. Acta Neuropathol. 1969; 14(1):19-37. DOI: 10.1007/BF00687700. View

Yokoi S, Austin J, Witmer F . Isolation and characterization of Lafora bodies in two cases of myoclonus epilepsy. J Neuropathol Exp Neurol. 1967; 26(1):125-7. View

Vanderhaeghen J . Correlation between ultrastructure and histochemistry of lafora bodies. Acta Neuropathol. 1971; 17(1):24-36. DOI: 10.1007/BF00684738. View

Holland J, Davis W, Prieur D, Collins G . Lafora's disease in the dog. A comparative study. Am J Pathol. 1970; 58(3):509-30. PMC: 2032841. View

10.

Schnabel R, Gootz M . [On the substructure of myoclonus bodies in progressive myoclonus epilepsy (Unverricht-type)]. Acta Neuropathol. 1971; 18(1):17-33. DOI: 10.1007/BF00684473. View

11.

Schnabel R, SEITELBERGER F . Histophysical and histochemical investigations of myoclonus bodies. Pathol Eur. 1968; 3(2):218-26. View

12.

Saunders A, ROSAN R . Histochemical nomenclature of carbohydrate-rich components. J Histochem Cytochem. 1966; 14(11):869. DOI: 10.1177/14.11.869. View

13.

ODOR D, JANEWAY R, Pearce L, RAVENS J . Progressive myoclonus epilepsy with Lafora inclusion bodies. II. Studies of ultrastructure. Arch Neurol. 1967; 16(6):583-94. DOI: 10.1001/archneur.1967.00470240021002. View

14.

TOGA M, Dubois D, Hassoun J . [Ultrastructure of Lafora bodies]. Acta Neuropathol. 1968; 10(2):132-42. DOI: 10.1007/BF00691307. View

15.

Rewcastle N . GLUTARIC ACID DIALDEHYDE; A ROUTINE FIXATIVE FOR CENTRAL NERVOUS SYSTEM ELECTRON MICROSCOPY. Nature. 1965; 205:207-8. DOI: 10.1038/205207b0. View

16.

Lope E, Ramon S, Junquera S, Berenguel A . Progressive myoclonic epilepsy with Lafora's bodies. A clinico-pathological study. Acta Neurol Scand. 1974; 50(5):537-52. DOI: 10.1111/j.1600-0404.1974.tb02800.x. View

17.

Yokoi S, Austin J, Witmer F, Sakai M . Studies in myoclonus epilepsy (Lafora body form). I. Isolation and preliminary characterization of Lafora bodies in two cases. Arch Neurol. 1968; 19(1):15-33. DOI: 10.1001/archneur.1968.00480010033002. View

18.

Fluharty A, Porter M, Hirsch G, Pevida E, Kihara H . Metachromasia in fibroblasts from a patient with Lafora's disease. Lancet. 1970; 1(7663):109-10. DOI: 10.1016/s0140-6736(70)92692-9. View

19.

Reynolds E . The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol. 1963; 17:208-12. PMC: 2106263. DOI: 10.1083/jcb.17.1.208. View

20.

Palade G . A study of fixation for electron microscopy. J Exp Med. 1952; 95(3):285-98. PMC: 2212069. DOI: 10.1084/jem.95.3.285. View